Deutsche Bank AG Purchases 5,448 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Deutsche Bank AG raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,354 shares of the company's stock after purchasing an additional 5,448 shares during the period. Deutsche Bank AG owned about 0.09% of Addus HomeCare worth $2,050,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Natixis raised its position in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare in the 4th quarter worth $77,000. Finally, Harvest Fund Management Co. Ltd bought a new position in shares of Addus HomeCare in the 4th quarter worth $86,000. 95.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ADUS has been the subject of several recent research reports. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Wall Street Zen lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Stephens reissued an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Wednesday, March 12th. Oppenheimer boosted their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Finally, Macquarie boosted their price target on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a research report on Thursday, May 8th. One analyst has rated the stock with a hold rating, six have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $111.53 on Friday. The business's 50-day moving average is $101.86 and its 200 day moving average is $113.41. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The firm has a market capitalization of $2.05 billion, a P/E ratio of 25.52, a P/E/G ratio of 1.41 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. During the same period in the prior year, the company posted $1.21 EPS. The firm's quarterly revenue was up 20.3% compared to the same quarter last year. On average, analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.